Dr. Amy Abernethy, a top FDA official who was reportedly considered for the commissioner’s job, plans to leave the agency by the end of April.
As principal deputy commissioner, Abernethy helps oversee the FDA’s day-to-day functioning and directs initiatives that cut across its regulatory centers covering drugs, medical devices, tobacco and food. She is also its acting chief information officer, overseeing the agency’s data and technical vision and execution.
Get the full story on our sister site, Medical Design & Outsourcing.